Preclinical efficacy of bacosides-lauric acid nano-herbal formulation incomparison to rivastigmine for treatment of Alzheimer's disease
A. Kumar, K. Goyal, M. Pal, P. Upadhyay, S. Gupta, V. Koul, A. Konar
This study evaluates a nano-herbal formulation of bacosides-lauric acid in preclinical models of Alzheimer's disease, showing reduced amyloid burden, neuroprotection, anti-inflammatory effects, and improved cognition compared to rivastigmine.
bioRxiv · Jun 25, 2022 · PreprintPharmacology & Toxicology